Potential anxiolytic properties of R-(+)-8-OSO2CF3-PAT, a 5-HT1A receptor agonist

European Journal of Pharmacology

Volumn 297, Issue 3, 1996, Pages 205-211

  Barf, Tjeerd ^a   Korte, S Mechiel ^a   Korte Bouws, Gerdien ^a   Sonesson, Clas ^b   Damsma, Geert ^a   Bohus, Béla ^a   Wikström, Håkan ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

5 H1AA 5 HT (5 hydroxy indole acetic acid 5 hydroxytryptamine) ratio; 5 HT1A receptor; Defensive burying; Inescapable footshock; Plus maze

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 8 [[(TRIFLUOROMETHYL)SULFONYL]OXY] 2 (PROPYLAMINO)TETRALIN; SEROTONIN; SEROTONIN 1A AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN HOMOGENATE; CONDITIONING; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; ELECTRIC SHOCK; HIPPOCAMPUS; HYPERPHAGIA; INTRAPERITONEAL DRUG ADMINISTRATION; LIMBIC SYSTEM; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTUM NUCLEUS; SEROTONIN BRAIN LEVEL; SOMATOSENSORY CORTEX; STRESS; TRANQUILIZING ACTIVITY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; BRAIN; HYDROXYINDOLEACETIC ACID; MALE; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGONISTS;

EID: 0030062451     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00782-2     Document Type: Article

References (38)

1. Azmitia, E.C. and M. Segal, 1978, An autoradiographic analysis of the different ascending projections of the dorsal and median raphe nuclei in the rat, J. Comp. Neur. 179, 641.
2. Blanchard, R.J., J.K. Shepherd, J. Armstrong, S.F. Tsuda and D.C. Blanchard, 1993, An ethopharmacological analysis of the behavioral effects of 8-OH-DPAT, Psychopharmacology 112, 55.
3. 1A agonist gepirone: electrophysiological studies in the rat brain, Synapse 1, 470.
4. Cimino, M., F. Ponzio, G. Achilli, G. Vantini, C. Perego, S. Algeri and S. Garattini, 1983, Dopaminergic effects of buspirone, a novel anxiolytic agent, Biochem. Pharmacol. 32, 1069.
5. Conti, L.H., C.R. Maciver, J.W. Ferkany and M.E. Abreu, 1990, Footshock-induced freezing behavior in rats as a model for assessing anxiolytics, Psychopharmacology 102, 492.
6. 1A Receptors, eds. C.T. Dourish, S. Ahlenius and P.H. Hutson (Ellis Horwood, Chichester) p. 233.
7. Cooper, S.J., 1989, Drugs interacting with 5-HT systems show promise for treatment of eating disorders, Trends Pharmacol. Sci. 10, 56.
8. Curzon, G., 1990, Serotonin and appetite, Ann. NY Acad. Sci. 600, 521.
9. De Boer, S.F., J.C. Slangen and J. Van der Gugten, 1990, Plasma catecholamine and corticosterone levels during active and passive prod avoidance behavior in rats: effects of chlordiazepoxide, Physiol. Behav. 47, 1089.
10. Dourish, C.T., P.H. Hutson and G. Curzon, 1985, Low doses of the putative serotonin agonist 8-hydroxy-2-(di-/i-propylamino)telralin (8-OH-DPAT) elicit feeding in the rat, Psychopharmacology 86, 197.
11. 1A autoreceptors in the raphe nuclei, Trends Pharmacol. Sci. 7, 212.
12. Guimaraes, F.S., E.A. Del Bel, C.M. Padovan, S. Mendonea Netto and R.T. De Almeida, 1994, Hippocampal 5-HT receptors and consolidation of stressful memories, Behav. Brain Res. 58, 133.
13. 1A agonists with potential anxiolytic properties, J. Pharmacol. Exp. Ther. 246, 745.
14. Handley, S.L. and J.W. McBlane, 1993a, An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J. Pharmacol. Toxicol. Methods 29, 129.
15. Handley, S.L. and J.W. McBlane, 1993h, 5HT drugs in animal models of anxiety, Psychopharmacology 112, 13.
16. 1A-like and GABA receptors in the dorsal raphe nucleus of the rat, Neuropharmacology 96, 829.
17. 1A receptor agonists in two models of anxiety after dorsal raphe injection. Psychopharmacology 106, 261.
18. 1A receptor agonist. 8-OH-DPAT, preferentially activates cell body autoreceptors in rat brain in vivo, Naunyn-Schmied. Arch. Pharmacol. 338, 463.
19. Hogg, S., N. Andrews and S.E. File, 1994, Contrasting behavioural effects of 8-OH-DPAT in the dorsal raphé nucleus and ventral hippocampus. Neuropharmacology 33, 343.
20. Hutson, P.H., T.P. Donohoe and G. Curzon, 1986, Neurochemical and behavioural evidence for an agonist action of 1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine (LY 165163) at central 5-HT receptors, Eur. J. Pharmacol. 138, 215.
21. Hutson, P.H., T.P. Donohoe and G. Curzon, 1988a, Infusion of the 5-hydroxytryptamine agonists, RU 24696 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia, Psychopharmacology 95, 550.
22. Hutson, P.H., C.T. Dourish and G. Curzon, 1988b, Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. Eur. J. Pharmacol. 129, 347.
23. Korte, S.M. and B. Bohus, 1990, The effect of ipsapirone on behavioural and cardiac responses in the shock-probe/defensive burying test in male rats, Eur. J. Pharmacol. 181, 307.
24. Korte, S.M., S.F. De Boer, E.R. De Kloet and B. Bohus, 1995, Anxiolytic-like effects of selective mineralo- and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze, Psychoneuroendocrinology 20, 385.
25. 1A receptors, J. Med. Chem. 36, 4221.
26. 2-receptor antagonists, J. Med. Chem. 38, 150.
27. 1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-( 1,2,5,6-tetrahydropyrid-4-yl)indole, J. Med. Chem. 33, 2087.
28. Pellow, S., P. Chopin, S.E. File and M. Briley, 1985, Validation of open: closed arm entries in elevated plus-maze as a measure of the anxiety in the rat, J. Neurosci. Methods 144, 149.
29. Pinel, J.P.J. and D. Treit, 1983, The conditioned defensive burying paradigm and behavioral neuroscience, in: Behavioral Approaches to Brain Research, ed. T.E. Robinson (Oxford University Press, Oxford) p. 212.
30. 1A receptors in the anti-conflict effect of ipsapironc, Neuropharmacology 33, 1109.
31. 1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin on neurochemical responses to stress, J. Neurochem. 64, 767.
32. Sonesson, C., M. Boije, K. Svensson, A. Ekman, A. Carlsson, A.G. Romero, I.J. Martin, J.N. Duncan, L.J. King and H. Wikslröm, 1993, Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[(trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)-tetralins and the formation of active metabolites in vivo, J. Med. Chem. 36, 3409.
33. Sonesson, C., T. Barf, J. Nilsson, D. Dijkstra, A. Carlsson, K. Svensson, M.W. Smith, I.J. Martin, J.N. Duncan. L.J. King and H. Wikström, 1995, Synthesis and evaluation of pharmacological and pharmacokinetic properties of monopropyl analogs of 5-, 7- and 8-[[(trifluoromethyl)sulfonyl]oxy]-2-aminotetralins: central dopamine and serotonin receptor activity, J. Med. Chem. 38, 1319.
34. 1B agonists, Synapse 1, 9.
35. Treit, D. and M. Fundytus, 1988, A comparison of buspirone and chlordiazepoxide in the shock-probe/burying test for anxiolytics, Pharmacol. Biochem. Behav. 31, 1071.
36. Treit, D., J.P.J. Pinel and H.C. Fibiger, 1981, Conditioned defensive burying: a new paradigm for the study of anxiolytic agents, Pharmacol. Biochem. Behav. 15, 619.
37. Treit, D., A. Robinson, S. Rotzinger and C. Pesold, 1993, Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test, Behav. Brain Res. 54, 23.
38. Vandermaelen, C.P., G.K. Matheson, R.C. Wilderman and L.A. Patterson, 1986, Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug, Eur. J. Pharmacol. 129, 123.